Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
about
Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers.Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes.Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3.Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia.Lipid metabolism and carcinogenesis, cancer development.
P2860
Q36594178-E833278B-32AA-4310-9403-A729164E7E4CQ36729421-239DF19D-6BD6-4394-B2FD-BBD912E5D34CQ38801030-541BC04F-7F74-4DFB-968F-B86C7AA05C10Q39250554-3B0DC0A9-09AF-4E52-9BF9-56DD126D0B06Q52373692-73C641D4-C06A-4D77-941E-9540E7546309Q52603655-7FA18A46-3A51-4D35-B0DB-7F8F701788A9Q55405747-95A0CD5F-EBEF-45DF-9237-71D04E2C5DED
P2860
Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Lovastatin enhances adenovirus ...... sion of prostate cancer cells.
@en
type
label
Lovastatin enhances adenovirus ...... sion of prostate cancer cells.
@en
prefLabel
Lovastatin enhances adenovirus ...... sion of prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Lovastatin enhances adenovirus ...... sion of prostate cancer cells.
@en
P2093
Chinghai Kao
Janet M Hock
Liangfang Shen
Lunquan Sun
Youhong Liu
Zhicheng Gong
P2860
P304
P356
10.18632/ONCOTARGET.3073
P407
P577
2015-02-01T00:00:00Z